Insmed | INSM - Trade Debtors

Stock Price
147.92
Daily Change
-2.08 -1.39%
Monthly
-5.11%
Yearly
81.39%
Q1 Forecast
159.80

Insmed reported $140.86M in Trade Debtors for its fiscal quarter ending in December of 2025.





Trade Debtors Change Date
BioMarin Pharmaceutical USD 908.21M 117.95M Dec/2025
Cytokinetics USD 1.81M 6.6M Sep/2025
DBV Technologies USD 15.97M 279K Sep/2025
Gilead Sciences USD 4.91B 182M Dec/2025
Heron Therapeutics USD 67.04M 6.9M Sep/2024
Insmed USD 140.86M 75.6M Dec/2025
Novartis USD 8.98B 192M Sep/2025
Regeneron Pharmaceuticals USD 5.74B 54M Dec/2025
Sarepta Therapeutics USD 398.23M 2.49M Dec/2025
Ultragenyx Pharmaceutical USD 112.54M 11.92M Sep/2025
Vertex Pharmaceuticals USD 2.05B 106.4M Dec/2025